Walter Berger

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Cancer Biology Cancer Biology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (26)

David Fabra-Escribano

Graduate Teaching Assistant

Universidad Autónoma de Madrid

SPAIN

View details

Michael Jakupec

Universität Wien

AUSTRIA

View details

Éva A. Enyedy

University of Szeged

HUNGARY

View details

Christopher Gerner

Full Professor

AUSTRIA

View details

Christian Kowol

Associate Professor

Universität Wien

AUSTRIA

View details

Alexander Kastner

Universität Wien

AUSTRIA

View details

Gunda Koellensperger

Professor

AUSTRIA

View details

Leonhard Müllauer

Pathologist/Molecular Pathologist/Associate Professor

Medical University of Vienna

AUSTRIA

View details

Bahil Ghanim

Karl Landsteiner University of Health Sciences

AUSTRIA

View details

Bernhard K. Keppler

AUSTRIA

View details

Adoracion Gomez Quiroga

Profesor Titular

Universidad Autónoma de Madrid

SPAIN

View details

Thomas Wanek

Medical University of Vienna

AUSTRIA

View details

Marcus Hacker

Univ. Prof. Dr. med., Full Professor for Nuclear Medicine and Director

Medical University of Vienna

AUSTRIA

View details

Petra Heffeter

Full professor

Medical University of Vienna

AUSTRIA

View details

Dominik Wenisch

Universität Wien

AUSTRIA

View details

ANA I MATESANZ

ASSOCIATE PROFESSOR

Universidad Autónoma de Madrid

SPAIN

View details

Astrid Slany

Universität Wien

AUSTRIA

View details

Evelyn Rampler

Assistant Professor

Universität Wien

AUSTRIA

View details

Liliia Legka

Nencki Institute of Experimental Biology

POLAND

View details

Vira Chumak

POLAND

View details

Claudia Kuntner

Assistant Professor

Medical University of Vienna

AUSTRIA

View details

Balazs Dome

Medical University of Vienna

AUSTRIA

View details

Doris Marko

Universität Wien

AUSTRIA

View details

Samuel M. Meier‐Menches

AUSTRIA

View details

Michael Grusch

Assoc. Prof.

Medical University of Vienna

AUSTRIA

View details

Frank Will

Prof. Dr., vice head institute, retired Sep. 30th, 2022

Hochschule Geisenheim University

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Walter Berger

Research Interests

Explore related searches

Contact this professor

Articles (21)

Exploring the Anticancer Properties of 4‐Phenylthiazole‐Based Ru(II) and Os(II) Metallacycles Featuring 1‐Methylimidazole as N‐Donor Functionality

Exploring the Structure–Activity Relationships of Albumin-Targeted Picoplatin-Based Platinum(IV) Prodrugs

Structural variations in the trans-carboxylate/chlorido axis that impact the mode of action of Pt(ii) complexes

Dual-Mode Wheat Germ Agglutinin Labeling – A Versatile Cell Segmentation Strategy for High-Resolution LA-ICP-TOFMS Bioimaging

LA-ICP-TOFMS Imaging Reveals Significant Influence of Cancer Cell Resistance on Oxaliplatin Compartmentalization in the Tumor Microenvironment

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors

A new fluorescent oxaliplatin(iv) complex with EGFR-inhibiting properties for the treatment of drug-resistant cancer cells

Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [<sup>18</sup>F]FDG-PET/MRI

Anthocyanin-Rich Berry Extracts Affect SN-38-Induced Response: A Comparison of Non-Tumorigenic HCEC-1CT and HCT116 Colon Carcinoma Cells

Precision Oncology Approach for Urachal Carcinoma: A Clinical Case Report

Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs

Cannabimimetic <i>N</i>-Stearoylethanolamine as “Double-Edged Sword” in Anticancer Chemotherapy: Proapoptotic Effect on Tumor Cells and Suppression of Tumor Growth versus Its Bio-Protective Actions in Complex with Polymeric Carrier on General Toxicity of Doxorubicin In Vivo

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment?

Multiparametric Tissue Characterization Utilizing the Cellular Metallome and Immuno-Mass Spectrometry Imaging

The Lipid Metabolism as Target and Modulator of BOLD‐100 Anticancer Activity: Crosstalk with Histone Acetylation

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance

The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation

Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib

Cisplatin Uptake in Macrophage Subtypes at the Single-Cell Level by LA-ICP-TOFMS Imaging

Collaborators (26)

David Fabra-Escribano

Michael Jakupec

Éva A. Enyedy

Christopher Gerner

Christian Kowol

Alexander Kastner

Gunda Koellensperger

Leonhard Müllauer

Bahil Ghanim

Bernhard K. Keppler

Adoracion Gomez Quiroga

Thomas Wanek

Marcus Hacker

Petra Heffeter

Dominik Wenisch

ANA I MATESANZ

Astrid Slany

Evelyn Rampler

Liliia Legka

Vira Chumak

Claudia Kuntner

Balazs Dome

Doris Marko

Samuel M. Meier‐Menches

Michael Grusch

Frank Will

Make your next move.